NO963052L - Fremgangsmåte for å solubilisere vanskelig opplöselige farmasöytisk aktive komponenter - Google Patents
Fremgangsmåte for å solubilisere vanskelig opplöselige farmasöytisk aktive komponenterInfo
- Publication number
- NO963052L NO963052L NO963052A NO963052A NO963052L NO 963052 L NO963052 L NO 963052L NO 963052 A NO963052 A NO 963052A NO 963052 A NO963052 A NO 963052A NO 963052 L NO963052 L NO 963052L
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutically active
- active components
- poorly soluble
- soluble pharmaceutically
- solubilizing poorly
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18557694A | 1994-01-24 | 1994-01-24 | |
PCT/US1995/001018 WO1995019759A1 (fr) | 1994-01-24 | 1995-01-24 | Procede pour solubiliser des agents pharmaceutiques difficilement solubles |
Publications (2)
Publication Number | Publication Date |
---|---|
NO963052D0 NO963052D0 (no) | 1996-07-22 |
NO963052L true NO963052L (no) | 1996-09-24 |
Family
ID=22681571
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO963052A NO963052L (no) | 1994-01-24 | 1996-07-22 | Fremgangsmåte for å solubilisere vanskelig opplöselige farmasöytisk aktive komponenter |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0741560A1 (fr) |
JP (1) | JPH09508128A (fr) |
CN (1) | CN1138827A (fr) |
AU (1) | AU706890B2 (fr) |
BR (1) | BR9506564A (fr) |
CA (1) | CA2181241C (fr) |
CZ (1) | CZ210496A3 (fr) |
FI (1) | FI962948A0 (fr) |
MX (1) | MX9602955A (fr) |
NO (1) | NO963052L (fr) |
NZ (1) | NZ279443A (fr) |
PL (1) | PL315635A1 (fr) |
SK (1) | SK96196A3 (fr) |
WO (1) | WO1995019759A1 (fr) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998058637A1 (fr) * | 1996-06-20 | 1998-12-30 | Mcneil-Ppc | Analgesique a base d'acetaminophene et de diphenhydramine |
ZA975444B (en) * | 1996-06-20 | 1998-12-21 | Mcneil Ppc Inc | Acetaminophen and meclizine hydrochloride analgesics |
FR2751875B1 (fr) * | 1996-08-05 | 1998-12-24 | Scr Newpharm | Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation |
US5763449A (en) * | 1996-08-07 | 1998-06-09 | Ascent Pediatrics, Inc. | Pleasant-tasting aqueous liquid composition of a bitter-tasting drug |
US6365180B1 (en) * | 1998-01-20 | 2002-04-02 | Glenn A. Meyer | Oral liquid compositions |
KR100610403B1 (ko) | 1998-01-20 | 2006-08-10 | 어플라이드 애널리티컬 인더스트리즈, 인크. | 경구용 액상 또는 반-고체 조성물을 포함하는 약제학적 조성물 및 이의 제조방법 |
US6846495B2 (en) | 1999-01-11 | 2005-01-25 | The Procter & Gamble Company | Compositions having improved delivery of actives |
US20020086878A1 (en) * | 1999-01-11 | 2002-07-04 | Douglas Joseph Dobrozsi | Compositions having improved stability |
US20020082307A1 (en) * | 1999-01-11 | 2002-06-27 | Dobrozsi Douglas Joseph | Compositions having improved stability |
US6211246B1 (en) * | 1999-06-10 | 2001-04-03 | Mcneil-Ppc, Inc. | Rapidly absorbed liquid compositions |
FR2796843B1 (fr) * | 1999-07-29 | 2003-05-09 | So Ge Val Sa | Composition antipyretique concentree et stabilisee a usage veterinaire destine a etre incorporee a l'alimentation des animaux ainsi que procede d'incorporation de cette composition a l'eau de boisson d'animaux |
US6251426B1 (en) * | 1999-09-02 | 2001-06-26 | Banner Pharmacaps, Inc. | Ibuprofen-containing softgels |
DE10011032A1 (de) * | 2000-03-07 | 2001-09-13 | Bayer Ag | Acetylsalicylsäure-Lösungen |
KR20020069387A (ko) * | 2001-02-26 | 2002-09-04 | 진양제약주식회사 | 호박산독실아민 조성물 및 이 조성물을 함유한 연질캅셀제제 |
JP2004538309A (ja) * | 2001-07-31 | 2004-12-24 | ワイエス | 不快な味覚をマスキングするためのスクラロース調合物 |
US7101572B2 (en) * | 2001-12-07 | 2006-09-05 | Unilab Pharmatech, Ltd. | Taste masked aqueous liquid pharmaceutical composition |
CN100379406C (zh) * | 2003-09-22 | 2008-04-09 | 北京德众万全药物技术开发有限公司 | 一种难溶性药物微丸的制备方法及包含该微丸的制剂 |
CN101360485B (zh) * | 2005-10-26 | 2013-04-17 | 班纳制药公司 | 作为胶囊填充物的基于亲水性载体的双重控释基质系统 |
DE102005053066A1 (de) | 2005-11-04 | 2007-05-10 | Basf Ag | Verwendung von Copolymeren als Solubilisatoren für in Wasser schwerlöslichen Verbindungen |
EP1962908A2 (fr) * | 2005-12-09 | 2008-09-03 | Basf Se | Utilisation de copolymeres blocs de lactame polyvinylique et d'oxyde de polyalkylene comme solubilisants dans des composes peu solubles dans l'eau |
US8637076B2 (en) | 2006-06-01 | 2014-01-28 | Cima Labs Inc. | Prednisolone salt formulations |
JP2008184430A (ja) * | 2007-01-30 | 2008-08-14 | Ss Pharmaceut Co Ltd | ソフトカプセル |
CA2690490C (fr) * | 2010-01-19 | 2012-06-26 | Accucaps Industries Limited | Formulations pharmaceutiques de loratadine pour encapsulation et combinaisons associees |
CA2690488C (fr) * | 2010-01-19 | 2013-06-11 | Accucaps Industries Limited | Formulations pharmaceutiques de naproxen pour encapsulation molle et combinaisons associees |
ES2609106T5 (es) | 2010-01-28 | 2020-11-10 | Eagle Pharmaceuticals Inc | Formulaciones de bendamustina |
HUE062230T2 (hu) | 2012-03-20 | 2023-10-28 | Eagle Pharmaceuticals Inc | Bendamusztin folyékony készítmények bendamusztinra reagáló állapotok kezelési eljárásban történõ alkalmazásra, ahol a betegek csökkentett térfogatú bevitelre szorulnak |
PT2827862T (pt) | 2012-03-20 | 2024-03-06 | Eagle Pharmaceuticals Inc | Formulações de bendamustina |
CN105007891B (zh) | 2013-02-28 | 2018-01-16 | 辉瑞公司 | 新液体组合物的增强的稳定性 |
GB201506755D0 (en) * | 2015-04-21 | 2015-06-03 | Reckitt Benckiser Llc | Novel pharmaceutical formulation |
TWI586379B (zh) | 2015-06-29 | 2017-06-11 | 永信藥品工業股份有限公司 | 一種製作難溶藥物固體劑型的方法 |
WO2017062997A1 (fr) | 2015-10-09 | 2017-04-13 | Reckitt Benckiser Llc | Formulation pharmaceutique |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5141961A (en) * | 1991-06-27 | 1992-08-25 | Richrdson-Vicks Inc. | Process for solubilizing difficulty soluble pharmaceutical actives |
-
1995
- 1995-01-24 SK SK961-96A patent/SK96196A3/sk unknown
- 1995-01-24 AU AU16075/95A patent/AU706890B2/en not_active Ceased
- 1995-01-24 CN CN95191303.4A patent/CN1138827A/zh active Pending
- 1995-01-24 PL PL95315635A patent/PL315635A1/xx unknown
- 1995-01-24 JP JP7519747A patent/JPH09508128A/ja active Pending
- 1995-01-24 EP EP95908124A patent/EP0741560A1/fr not_active Withdrawn
- 1995-01-24 WO PCT/US1995/001018 patent/WO1995019759A1/fr not_active Application Discontinuation
- 1995-01-24 NZ NZ279443A patent/NZ279443A/en unknown
- 1995-01-24 CA CA002181241A patent/CA2181241C/fr not_active Expired - Fee Related
- 1995-01-24 BR BR9506564A patent/BR9506564A/pt not_active Application Discontinuation
- 1995-01-24 MX MX9602955A patent/MX9602955A/es unknown
- 1995-01-24 CZ CZ962104A patent/CZ210496A3/cs unknown
-
1996
- 1996-07-22 NO NO963052A patent/NO963052L/no not_active Application Discontinuation
- 1996-07-23 FI FI962948A patent/FI962948A0/fi unknown
Also Published As
Publication number | Publication date |
---|---|
MX9602955A (es) | 1997-06-28 |
AU1607595A (en) | 1995-08-08 |
PL315635A1 (en) | 1996-11-25 |
EP0741560A1 (fr) | 1996-11-13 |
CZ210496A3 (en) | 1996-12-11 |
WO1995019759A1 (fr) | 1995-07-27 |
CA2181241C (fr) | 2000-04-25 |
BR9506564A (pt) | 1997-09-02 |
SK96196A3 (en) | 1997-03-05 |
AU706890B2 (en) | 1999-07-01 |
CN1138827A (zh) | 1996-12-25 |
CA2181241A1 (fr) | 1995-07-27 |
JPH09508128A (ja) | 1997-08-19 |
FI962948A (fi) | 1996-07-23 |
NO963052D0 (no) | 1996-07-22 |
FI962948A0 (fi) | 1996-07-23 |
NZ279443A (en) | 1998-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO963052L (no) | Fremgangsmåte for å solubilisere vanskelig opplöselige farmasöytisk aktive komponenter | |
PL300194A1 (en) | Interferon conjugate, method of obtaining same and pharmaceutical composition containing it | |
NO971889L (no) | Forbindelser og sammensetninger for levering av aktive midler | |
DK0620828T3 (da) | Cyclodextrinderivater med forøget vandopløselighed og anvendelse deraf | |
CA2258548A1 (fr) | Derives tricycliques substitues par phenylamino, destines au traitement des maladies hyperproliferatives | |
LU90987I2 (fr) | Copaxone et ses dérivés pharmaceutiquement acceptables | |
NO944764L (no) | Inklusjonskomplekser i vandige opplösninger av benzotiofenforbindelser med vannopplöselige cyklodekstriner og farmasöytiske formuleringer og fremgangsmåter | |
WO1996015786A3 (fr) | Compositions orales contenant de l'ondansetron | |
TR199801861T2 (xx) | Farmas�tik olarak yararl� bile�imler. | |
AU661591B2 (en) | 5,10-methylenetetrahydrofolic acid-cyclodextrin inclusion compounds | |
FI910895A (fi) | Menetelmä terapeuttisesti käyttökelpoisen 4-(di-n-propyyli)amino-6-aminokarbonyyli-1,3,4,5-tetrahydrobentso/c,d/indolihippuraatin valmistam iseksi | |
CA2089853A1 (fr) | Conjugues polyethyleneglycol-hirudine, leur procede de preparation et leur emploi pour le traitement des thromboses | |
IL129616A0 (en) | Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | |
FR2701478B1 (fr) | Dérivés de vitamine E contenant de l'azote quaternaire et procédés pour leur préparation. | |
IL129625A0 (en) | Novel (-)-enantionmers of CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | |
IE890275L (en) | Pharmaceutical composition for 4-aroylimidazol-2-ones | |
IT1257000B (it) | Derivati dell'eserolina ad attivita` anticolinesterasica, procedimento per la loro preparazione e composizioni farmaceutiche cheli contengono. | |
MX9601756A (es) | Composicion liquida estable que contiene urato-oxidasa, y composicion liofilizada para su preparacion. | |
ES2150400A6 (es) | Una composicion para el tratamiento de desordenes ulcerosos del tracto gastrointestinal. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |